Autres langues Sanofi

Actions

SAN

FR0000120578

Produits pharmaceutiques

Marché Fermé - 17:55:00 25/09/2026 Après clôture 21:59:57
71,79 EUR -0,43% Graphique intraday de Sanofi 71,88 +0,13%

Autres langues

17:51 Linde: Warum das Unternehmen überall präsent ist, obwohl kaum jemand den Namen kennt
10:57 Why is Linde everywhere even though hardly anyone knows its name?
08:28 Linde está en todas partes y nadie la conoce
03:25 Singapore Pushes Local mRNA Vaccine Production to Boost Pandemic Preparedness
24/09 Waarom is Linde overal zonder dat iemand de naam kent?
24/09 Twintig jaar Europese beursgeschiedenis in tien aandelen
24/09 US FDA approves Lilly's once-weekly insulin injection for type 2 diabetes
24/09 20 Jahre europäische Börsengeschichte in zehn Aktien
24/09 Vent'anni di Borsa europea raccontati attraverso dieci titoli
23/09 European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
23/09 Veinte años de bolsa europea contados a través de diez valores
23/09 Twenty years of Europe's stock market told through ten stocks
22/09 European Pharma Leaders Push for National Reforms to Boost Investment
22/09 European drugmakers call for faster trials, more spending to compete with US, China
21/09 Pharma sector doubles down on AI to slash costs, timelines
18/09 Sanofi's Rabies Vaccine VaxRabeo Recommended for EU Approval
17/09 Bavarian Nordic Names New CEO/President
16/09 Sanofi Inaugurates Charles Best Building Flu Vaccine Manufacturing Facility in Toronto
16/09 Sanofi Opens New Flu Vaccine Facility in Toronto
16/09 Cheplapharm hat nach Sanofi-Einstieg Appetit auf mehr
16/09 Sanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investment
16/09 Pharma sector doubles down on AI to slash costs, timelines
14/09 Sanofi and Cheplapharm Create Strategic Partnership in Mature Medicines
14/09 European Stocks Close Mixed in Monday Trading; ECB Rates Could Rise as Energy Costs Fuel Inflation
14/09 Cheplapharm aus Greifswald und Sanofi vor Milliarden-Deal
Aucun résultat pour cette recherche